Shypd.aiThe largest open index of AI tools
WhiteLab Genomics is an AI-driven platform that accelerates genomic medicine development. It leverages AI and computational biology to optimize drug design for enhanced safety and efficacy.
Trending
Also listed in
About
WhiteLab Genomics is an AI-driven platform founded in 2019, backed by Y-Combinator, dedicated to accelerating the development of life-saving genomic medicines. The platform utilizes its proprietary AI-led framework, ALFRED (AI-Led Framework for Rational Exploration in Drug Design), which combines advanced algorithms, curated databases, and cutting-edge computational biology. This technology optimizes therapeutic candidates across diverse modalities such as AAV, lentivirus, and nanoparticles, focusing on safety and efficacy. WhiteLab Genomics supports various applications including gene and RNA-based therapies, target receptor identification, viral vector design, non-viral vector design, payload design, and bioproduction optimization. It aims to significantly accelerate and de-risk drug development processes.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check whitelabgx.com for current pricing.
FAQs
Trending
